Diltiazem
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names:
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
Dosage must be adjusted to each patient's needs.
Starting with 30 mg four times daily, before meals and at bedtime, dosage should be increased gradually (given in divided doses three or four times daily) at one- to two-day intervals until optimum response is obtained.
Although individual patients may respond to any dosage level, the average optimum dosage range appears to be 180 to 360 mg/day.
There are no available data concerning dosage requirements in patients with impaired renal or hepatic function. If the drug must be used in such patients, titration should be carried out with particular caution.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Warnings
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Diltiazem
Return to top
Publication Resources
Most Recent Articles on Diltiazem
Review Articles on Diltiazem
Articles on Diltiazem in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Diltiazem
Return to top
Trial Resources
Ongoing Trials with Diltiazem at Clinical Trials.gov
Trial Results with Diltiazem
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Diltiazem
Cochrane Collaboration on Diltiazem
Cost Effectiveness of Diltiazem
Return to top
Media Resources
Powerpoint Slides on Diltiazem
Images of Diltiazem
Podcasts & MP3s on Diltiazem
Videos on Diltiazem
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Diltiazem
Discussion Groups on Diltiazem
Patient Handouts on Diltiazem
Blogs on Diltiazem
Diltiazem in the News
Diltiazem in the Marketplace
Return to top
International Resources
Diltiazem en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
